“The best feature of the book is the chapter summaries. These are succinct and very readable –ideal for clinicians needing a quick reference, students requiring clear and precise details about the drug’s safety, or academics wanting a taste of the complexities that lie within the chapter’s text. Even for just these summaries, investment in this book is worthwhile.” (Nicholas Farinola, Medical Journal of Australia, Vol. 207 (4), August, 2017) “This book has a very ambitious goal of providing an up-to-date review of a wide range of biologics used as therapeutic agents and it is clearly stated that there are many new biologics being developed that will be approved for clinical use in the near future. … this is a comprehensive compilation of information that will serve as a very useful reference book for clinicians and anyone interested in the use of biologics in medicine.” (Kevin Broady, Drug Safety, Vol. 40 (7), July, 2017)“A comprehensive, concise and up-to-date guide to approved biologic medicines predominantly produced by rDNA technology. … The chapters follow a logical sequence and are well structured; the illustrations are of high quality, and the numerous tables convey accurate and pertinent information. The book is an excellent reference text for experts in the field and biologics industry stakeholders, and as a general educational reference book for students looking to expand their knowledge in the increasingly important area of biopharmaceutical products.” (Stephen Mahler, mAbs, Vol. 9 (6), July, 2017) “Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins … is a book that belongs on the shelf of everyone in the field of biologic therapies research and clinical practice. … an informative and easily readable book. It will be helpful for students, fellows, clinicians, and researchers who wish to improve their knowledge of the biology, pharmacological efficacy, and safety of biological drugs.” (Tadeusz Robak, Biologics Targets and Therapy, Vol. 11, 2017)“The primary goal is to produce an up-to-date book on approved biologic therapies in this climate of rapid ever-expanding developments in biotherapeutic research … . This book targets all scientists and clinicians involved in development, handling, prescribing, administering, or managing patients with biologics for the treatment of diseases. … I highly recommend this exciting book to anyone who is involved in developing or administering these novel disease-targeted medications that fall under the broad umbrella term of biologics.” (Thomas L. Pazdernik, Doody's Book Reviews, November, 2016)
